JIDE yields 4.39% · PFE yields 6.20%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, JIDE + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JIDE + PFE for your $10,000?
JIDE is an actively managed fund focused on large- and mid-cap stocks in developed markets outside North America, such as Japan, Europe, and the UK. With holdings similar to those found in the MSCI EAFE Index, it is unconstrained by style or sector and may invest in securities denominated in major global currencies. Utilizing a core, best ideas portfolio, the adviser combines bottom-up fundamental analysis with data-driven insights, aiming to identify companies with positive fundamentals and improving outlooks at reasonable valuations. Environmental, social, and governance (ESG) factors are also considered during the investment process. The fund may use derivatives, primarily exchange-traded futures, and can adjust allocations by country, sector, or security type based on market conditions and outlook. Holdings may be sold if fundamentals deteriorate, valuations become unattractive, or better opportunities arise.
Full JIDE Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.